Tandem Diabetes Care, Inc. announced U.S. Food and Drug Administration (FDA) clearance for the Tandem Mobi insulin pump for people with diabetes age 6 and up, expanding the company's portfolio of products. The Tandem Mobi is fully controllable from a mobile app and is the durable automated insulin delivery system. Key Tandem Mobi System Features: The Tandem Mobi features a 200-unit insulin cartridge and an on-pump button that provides an alternative option to phone control for bolusing insulin.

Additional features include: Multiple Wear Options - Less than half the size of the t:slim X2 pump, Tandem Mobi can fit in a coin pocket, be clipped to clothing, or worn on-body with an adhesive sleeve (sold separately). Detachable Infusion Sets - Compatible with all existing Tandem-branded infusion sets manufactured by the Convatec Group, including a new five-inch tubing option made just for Tandem Mobi. Infusion sets allow users to temporarily disconnect from their pump for convenience and provide the flexibility of more than 30 mix-and-match infusion site and tubing length combinations.

AID Compatibility - Designed for use as part of an automated insulin delivery (AID) system, the Tandem Mobi features Control-IQ technology. Mobile App Control - Full iOS mobile control through a user's compatible iPhone. Modern Technology - Inductive charging and capable of wireless remote software updates via a compatible smartphone.

A limited release of Tandem Mobi is expected to start in late 2023 with full commercial availability planned in early 2024.